Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip World Congress

Albert Folch's Biography

Albert Folch, Associate Professor of Bioengineering, University of Washington

Albert Folch received his BSc in physics from the University of Barcelona (UB), Spain, in 1989. In 1994, he received his PhD in surface science and nanotechnology from the UB’s Physics Dept. During his PhD he was a visiting scientist from 1990–91at the Lawrence Berkeley Lab working on AFM under Dr. Miquel Salmeron. From 1994–1996, he was a postdoc at MIT developing MEMS under the advice of Martin Schmidt (EECS) and Mark Wrighton (Chemistry). In 1997, he joined the laboratory of Mehmet Toner as a postdoc at Harvard’s Center for Engineering in Medicine to apply soft lithographic methods to tissue engineering. He has been at Seattle’s UW BioE since June 2000 where he is an Associate Professor. His lab works at the interface between microfluidics, neurobiology and cancer. In 2001 he received a NSF Career Award and in 2014 he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows (Class of 2015). He serves on the Advisory Board of Lab on a Chip since 2006. Albert Folch is the author of four books, including “Introduction to BioMEMS”, a textbook now adopted by more than 68 departments in 14 countries (including 40 universities in the U.S. alone). Since 2007, the lab runs a celebrated outreach art program called BAIT (Bringing Art Into Technology) which has produced six exhibits, a popular resource gallery of >2,000 free images related to microfluidics and microfabrication, and a YouTube channel that plays microfluidic videos with music which accumulates ~120,000 visits since 2009.

Albert Folch Image

Tubeless Microfluidic Systems for Personalized Chemotherapy

Tuesday, 25 September 2012 at 09:00

Add to Calendar ▼2012-09-25 09:00:002012-09-25 10:00:00Europe/LondonTubeless Microfluidic Systems for Personalized Chemotherapy Lab-on-a-Chip World Congress in San Diego, USASan Diego,

Presently, oncologists do not directly assess tumor chemosensitivity prior to choosing a chemotherapeutic regimen, resulting in inefficient therapies. Here we show a multiplexed microfluidic assay that utilizes intact tumor tissue and could be used to rapidly predict tumor chemosensitivity to a large panel of drugs prior to initiation of therapy.

Add to Calendar ▼2012-09-25 00:00:002012-09-26 00:00:00Europe/LondonLab-on-a-Chip World CongressLab-on-a-Chip World Congress in San Diego, USASan Diego,